Ingram R, Volianskis R, Georgiou J, Jane D, Michael-Titus A, Collingridge G
Philos Trans R Soc Lond B Biol Sci. 2024; 379(1906):20230239.
PMID: 38853568
PMC: 11343233.
DOI: 10.1098/rstb.2023.0239.
Schmidt C, Tong R, Emptage N
Philos Trans R Soc Lond B Biol Sci. 2024; 379(1906):20230222.
PMID: 38853550
PMC: 11343232.
DOI: 10.1098/rstb.2023.0222.
Hanson J, Yuan H, Perszyk R, Banke T, Xing H, Tsai M
Neuropsychopharmacology. 2023; 49(1):51-66.
PMID: 37369776
PMC: 10700609.
DOI: 10.1038/s41386-023-01614-3.
Seifried L, Soleimanpour E, Dieterich D, Fendt M
Cells. 2023; 12(9).
PMID: 37174612
PMC: 10177518.
DOI: 10.3390/cells12091212.
Xie M, Leng T, Maysami S, Pearson A, Simon R, Xiong Z
Biomolecules. 2022; 12(9).
PMID: 36139053
PMC: 9496625.
DOI: 10.3390/biom12091214.
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System.
Lemarchant S, Sourioux M, Le Douce J, Henriques A, Callizot N, Hugues S
Int J Mol Sci. 2022; 23(16).
PMID: 36012124
PMC: 9408760.
DOI: 10.3390/ijms23168867.
Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.
Niu M, Yang X, Li Y, Sun Y, Wang L, Ha J
Cell Mol Neurobiol. 2022; 43(1):139-153.
PMID: 34978648
PMC: 11415211.
DOI: 10.1007/s10571-021-01185-1.
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Hansen K, Wollmuth L, Bowie D, Furukawa H, Menniti F, Sobolevsky A
Pharmacol Rev. 2021; 73(4):298-487.
PMID: 34753794
PMC: 8626789.
DOI: 10.1124/pharmrev.120.000131.
CPP impairs contextual learning at concentrations below those that block pyramidal neuron NMDARs and LTP in the CA1 region of the hippocampus.
Laha K, Zhu M, Gemperline E, Rau V, Li L, Fanselow M
Neuropharmacology. 2021; 202:108846.
PMID: 34687710
PMC: 8627488.
DOI: 10.1016/j.neuropharm.2021.108846.
Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.
Mares P, Tsenov G, Kubova H
Pharmaceutics. 2021; 13(3).
PMID: 33808912
PMC: 8003757.
DOI: 10.3390/pharmaceutics13030415.
Synaptic control of DNA methylation involves activity-dependent degradation of DNMT3A1 in the nucleus.
Bayraktar G, Yuanxiang P, Confettura A, Gomes G, Raza S, Stork O
Neuropsychopharmacology. 2020; 45(12):2120-2130.
PMID: 32726795
PMC: 7547096.
DOI: 10.1038/s41386-020-0780-2.
Brain NMDA Receptors in Schizophrenia and Depression.
Adell A
Biomolecules. 2020; 10(6).
PMID: 32585886
PMC: 7355879.
DOI: 10.3390/biom10060947.
Activation of GSK3β induced by recall of cocaine reward memories is dependent on GluN2A/B NMDA receptor signaling.
Shi X, von Weltin E, Barr J, Unterwald E
J Neurochem. 2019; 151(1):91-102.
PMID: 31361029
PMC: 6788955.
DOI: 10.1111/jnc.14842.
Role of GluN2A NMDA receptor in homocysteine-induced prostaglandin E2 release from neurons.
Rajagopal S, Fitzgerald A, Deep S, Paul S, Poddar R
J Neurochem. 2019; 150(1):44-55.
PMID: 31125437
PMC: 7263633.
DOI: 10.1111/jnc.14775.
Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.
Jindal A, Rajagopal S, Winter L, Miller J, Jacobsen D, Brigman J
Neurobiol Dis. 2019; 127:287-302.
PMID: 30885791
PMC: 6588434.
DOI: 10.1016/j.nbd.2019.03.012.
Colocalization of distinct NMDA receptor subtypes at excitatory synapses in the entorhinal cortex.
Beesley S, Sullenberger T, Pilli J, Abbasi S, Gunjan A, Kumar S
J Neurophysiol. 2018; 121(1):238-254.
PMID: 30461362
PMC: 6383656.
DOI: 10.1152/jn.00468.2018.
Agmatine preferentially antagonizes GluN2B-containing N-methyl-d-aspartate receptors in spinal cord.
Waataja J, Peterson C, Verma H, Goracke-Postle C, Seguela P, Delpire E
J Neurophysiol. 2018; 121(2):662-671.
PMID: 30427758
PMC: 6397392.
DOI: 10.1152/jn.00172.2018.
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate.
Yeboah F, Guo H, Bill A
J Vis Exp. 2018; (137).
PMID: 30059041
PMC: 6126451.
DOI: 10.3791/58160.
Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist.
Gordillo-Salas M, Pilar-Cuellar F, Auberson Y, Adell A
Transl Psychiatry. 2018; 8(1):84.
PMID: 29666360
PMC: 5904130.
DOI: 10.1038/s41398-018-0131-9.
HIPK2-Mediated Transcriptional Control of NMDA Receptor Subunit Expression Regulates Neuronal Survival and Cell Death.
Shang Y, Zhang J, Huang E
J Neurosci. 2018; 38(16):4006-4019.
PMID: 29581378
PMC: 5907057.
DOI: 10.1523/JNEUROSCI.3577-17.2018.
